Renal Failure
Conditions
Brief summary
Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.
Interventions
None listed
Sponsors
University of California, Davis
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients greater than or equal to 18 years old that underwent renal transplant at UC Davis Medical Center -
Exclusion criteria
Patients that did not undergo renal transplants and patients less than 18 years old will be excluded from the study. \-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cr/GFR improvement, postoperative mortality/morbidity (within 30 days) and overall complications | 5 years |
Secondary
| Measure | Time frame |
|---|---|
| Graft failure, length of hospital stay (LOS), length of ICU stay, re-admission rate, infections, pulmonary complications. | 5 years |
Other
| Measure | Time frame |
|---|---|
| length of intubation time, and length of ventilation time | 5 years |
Countries
United States
Outcome results
None listed